Vitamin D may help prevent a common side effect of anti-cancer immunotherapy
(Wiley) New research published in CANCER indicates that taking vitamin D supplements may help prevent a potentially serious side effect of a revolutionary form of anti-cancer therapy. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 22, 2020 Category: Biology Source Type: news

Biocon to expand generic drugs business with DKSH
As a part of the pact, DKSH will gain an exclusive license to register and commercialize these seven generic formulations from various therapeutic areas like diabetology, cardiology, oncology and immunology, which will be sold under Biocon ’s brand in these key Asian markets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 22, 2020 Category: Pharmaceuticals Source Type: news

Aspergillosis in the Presence of Squamous Cell Carcinoma
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - June 21, 2020 Category: Respiratory Medicine Authors: MeganB Source Type: news

Lung cancer warning - the subtle sound when you breathe that could be serious
LUNG cancer symptoms include difficulty breathing, headaches, and persistent chest pain. But you could also be at risk of a tumour if you hear a quiet, subtle sound when you breathe. Could you be at risk of lung cancer? (Source: Daily Express - Health)
Source: Daily Express - Health - June 21, 2020 Category: Consumer Health News Source Type: news

Now breast, lung, bowel and prostate cancer can all be treated in a WEEK
Studies and trials have shown five days of treatment, or less, can be just as effective at blasting away tumours (pictured: Karen Davis, 52, whose breast cancer radiotherapy took five days). (Source: the Mail online | Health)
Source: the Mail online | Health - June 21, 2020 Category: Consumer Health News Source Type: news

Checking for prostate cancer could save your life
One in eight men get prostate cancer in the UK, but swift action saves lives, as Gary Pettit discovered... (Source: Daily Express - Health)
Source: Daily Express - Health - June 21, 2020 Category: Consumer Health News Source Type: news

Bowel cancer warning: Common symptom you may be missing - should you speak to a doctor?
BOWEL cancer symptoms include weight loss, stomach pain, and unexplained bleeding. But you could also be at risk of the disease if you notice a subtle change to your daily lifestyle. Should you speak to a doctor about persistent tiredness or fatigue? (Source: Daily Express - Health)
Source: Daily Express - Health - June 20, 2020 Category: Consumer Health News Source Type: news

Mental disorders and suicide risk among cancer patients: a nationwide cohort study - Choi JW, Park EC, Kim TH, Han E.
Although cancer patients are known to experience mental disorders and face suicide risk, little is known about the relationship between mental illness and death by suicide in this group. As such, this study aims to examine the association between mental di... (Source: SafetyLit)
Source: SafetyLit - June 20, 2020 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news

Breakthrough discovery to transform prostate cancer treatment
(University of South Australia) A novel formulation of the prostate cancer drug abiraterone acetate - currently marketed as Zytiga - will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University of South Australia show the new formulation improves the drug's effectiveness by 40 per cent. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 20, 2020 Category: Biology Source Type: news

Shining light on a malignant lung cancer
(Nagoya University) Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. Nagoya University oncologist Kazuhide Sato and colleagues tested the treatment and published their findings in the journal Cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 20, 2020 Category: International Medicine & Public Health Source Type: news

' Unbelievably Exciting' Results in Rare Type of Breast Cancer'Unbelievably Exciting' Results in Rare Type of Breast Cancer
Three (of 17) women with advanced metaplastic breast cancer treated with a combination of immunotherapies showed dramatic and durable responses.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 20, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

App determines COVID-19 disease severity using artificial intelligence, biomarkers
COVID-19 severity score, built with data from china and new york city, can help clinicians identify the most at-risk patientsNew York UniversityA new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases. Created by researchers at NYU College of Dentistry, the app uses artificial intelligence (AI) to assess risk factors and key biomarkers from blood tests, producing a COVID-19 " severity score. "Current diagnostic tests for COVID-19 detect viral RNA to determine whether someone does or does not have the virus--but they do not provide clues as...
Source: Dental Technology Blog - June 20, 2020 Category: Dentistry Source Type: news

'Natural killers' against cancer bolster Peninsula biotech's $100M IPO
Leaders of the South San Francisco company believe its engineered cells offer the latest immunotherapy attack against cancers, including potentially colorectal and liver tumors. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 19, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

'Natural killers' against cancer bolster Peninsula biotech's $100M IPO
Leaders of the South San Francisco company believe its engineered cells offer the latest immunotherapy attack against cancers, including potentially colorectal and liver tumors. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 19, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Peninsula startup ’s all-star lineup, fresh off $192M round, circles next-generation cell therapies
Touting a board that includes the former head of the National Cancer Institute, the ex-CEO of Novartis and a well-known Stanford University researcher, a young Peninsula company emerged with a $192 million round to attack cancer and other diseases with off-the-shelf cell therapies. Orca Bio — incubated at the nonprofit StartX accelerator program associated with Stanford — said Wednesday that its Series D funding was led by Lightspeed Venture Partners and an undisclosed investor. Founders Ivan… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 19, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

The Treatment of Bone Metastases From Breast Cancer The Treatment of Bone Metastases From Breast Cancer
A new review provides a summary of current and new options for the treatment and management of bone metastases of breast cancer.Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 19, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Does Radiotherapy Boost Prostate-Cancer Survival? Does Radiotherapy Boost Prostate-Cancer Survival?
Radiotherapy appears to provide better survival outcomes in men with low- and intermediate-risk localized prostate cancer, compared with focal laser ablation, according to a database study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - June 19, 2020 Category: Radiology Tags: Hematology-Oncology News Source Type: news

FDA Gives Thumbs Up to Tazemetostat for Follicular Lymphoma FDA Gives Thumbs Up to Tazemetostat for Follicular Lymphoma
The FDA has granted accelerated approved of the EZH2 inhibitor tazemetostat (Tazverik) for the treatment of relapsed or refractory follicular lymphoma.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 19, 2020 Category: Cancer & Oncology Tags: Pharmacist News Alert Source Type: news

Health Highlights: June 19, 2020
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Too Much Sitting Increases Risk of Cancer Death: Study Sitting too much could increase your risk of dying from cancer, a new study warns. It... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 19, 2020 Category: General Medicine Source Type: news

How Quick Is the Recovery After Fibula Flap Surgery?
Title: How Quick Is the Recovery After Fibula Flap Surgery?Category: Procedures and TestsCreated: 6/19/2020 12:00:00 AMLast Editorial Review: 6/19/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 19, 2020 Category: Cancer & Oncology Source Type: news

How Bad Is Lymphoma Cancer Of Bone?
Title: How Bad Is Lymphoma Cancer Of Bone?Category: Diseases and ConditionsCreated: 6/19/2020 12:00:00 AMLast Editorial Review: 6/19/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 19, 2020 Category: Cancer & Oncology Source Type: news

Too Much Sitting Increases Risk of Cancer Death: Study
Title: Too Much Sitting Increases Risk of Cancer Death: StudyCategory: Health NewsCreated: 6/19/2020 12:00:00 AMLast Editorial Review: 6/19/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 19, 2020 Category: Cancer & Oncology Source Type: news

Roche ’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints
      ·Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary endpoint of radiographic progression free survival (rPFS) in patients with PTEN loss tumoursBasel, 19 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCR...
Source: Roche Media News - June 19, 2020 Category: Pharmaceuticals Source Type: news

Roche ’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints
Basel, 19 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC) and whose tumours had PTEN loss. In this patient group, ipatasertib in combination with abiraterone and prednisone/prednisolone provided a statistically significant reduction in the risk of disease worsening or death, compared to current standard of care (abiraterone and prednisone/prednisolone) plus placebo. The other co-primary endpoint of rPFS in the overal...
Source: Roche Investor Update - June 19, 2020 Category: Pharmaceuticals Source Type: news

Research priorities on falls in older adults with cancer - Sattar S, Haase K, Wildes T.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - June 19, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Early clinical trial supports tumor cell-based vaccine for mantle cell lymphoma
(Rockefeller University Press) A phase I/II clinical trial by researchers at Stanford University suggests that vaccines prepared from a patient's own tumor cells may prevent the incurable blood cancer mantle cell lymphoma (MCL) from returning after treatment. The study, which will be published June 19 in the Journal of Experimental Medicine (JEM), reveals that the vaccines are a safe and effective way to induce the body's immune system to attack any tumor cells that could cause disease relapse. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 19, 2020 Category: Cancer & Oncology Source Type: news

Researchers attempt new treatment approach for blood cancer
(Boston University School of Medicine) In an effort to improve the survival of patients with myeloproliferative neoplasms, a type of leukemia, researchers inhibited a specific protein (alpha5beta1 integrin) to decrease the number of large bone marrow cells (megakaryocytes) in an experimental model. An increase in megakaryocyte numbers is thought to be the cause of many problems observed in this disease. This type of treatment approach has never been attempted before. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2020 Category: International Medicine & Public Health Source Type: news

Renewed hope for treatment of pain and depression
(Luxembourg Institute of Health) Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby modulating the levels of opioid peptides produced in the central nervous system (CNS) and potentiating their natural painkilling and antidepressant properties. These findings were published on June 19th in the prestigious international journal 'Nature Communications'. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 19, 2020 Category: Cancer & Oncology Source Type: news

A novel radioisotope therapy for children with neuroblastoma
(Kanazawa University) Researchers from Kanazawa University retrospectively analyzed children with refractory or relapsed high-risk neuroblastoma who were treated with high-dose131I-metaiodobenzylguanidine at Kanazawa University Hospital. They showed that within a 5-year period, this therapy could provide a favorable prognosis without severe non-hematological side effects. These findings could provide new insights into a novel treatment option for patients with high-risk neuroblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 19, 2020 Category: Cancer & Oncology Source Type: news

$400,000 SBIR grant fast-tracks new approach to treating lung, thyroid cancers
(Purdue University) A $399,933 SBIR Phase I grant from the National Cancer Institute to KinaRx, a Purdue University-affiliated startup, will help to advance a novel platform aimed at producing more effective drugs to treat lung and thyroid cancers. The platform targets gene mutations that help cancers grow and expand within the body. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 19, 2020 Category: Biology Source Type: news

Too much sitting raises your cancer risk, study finds
Too much sitting can raise the risk for cancer, but you can overcome it with movement, a new study finds. Replacing at least 30 minutes of sitting with either light, moderate or vigorous physical activity can lower that risk. (Source: CNN.com - Health)
Source: CNN.com - Health - June 19, 2020 Category: Consumer Health News Source Type: news

Nation’s cancer chief warns delays in cancer care are likely to result in thousands of extra deaths in coming years
Norman "Ned" Sharpless, the director of the National Cancer Institute, warned that pandemic-related delays in cancer screenings, diagnoses and treatments will result in thousands of deaths that otherwise would not have occurred. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 19, 2020 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

Too much sitting raises your risk for cancer, study finds
Need another reason to get off the couch and get moving while cooped up during the coronavirus epidemic? (Source: CNN.com - Health)
Source: CNN.com - Health - June 19, 2020 Category: Consumer Health News Source Type: news

Philips to collaborate with American Telemedicine
Royal Philips subsidiary Philips Healthcare has announced that it will collaborate...Read more on AuntMinnie.comRelated Reading: Philips teams up with MD Anderson in oncology Philips launches Lumify ultrasound scanner in Japan Philips to distribute SyntheticMR software Philips gets FDA nod for ultrasound for COVID-19 Philips releases pediatric ultrasound package (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 19, 2020 Category: Radiology Source Type: news

Breast screening interventions are cost-effective
Interventions designed to help underserved and vulnerable women in the U.S....Read more on AuntMinnie.comRelated Reading: Experts recommend Facebook to promote breast screening Poor, rural women less likely to get breast cancer screening Breast screening reduces race-related cancer disparities Hey, Alexa -- Tell me about breast density Death risk higher for government-insured breast cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 19, 2020 Category: Radiology Source Type: news

Dr Reddy's launches generic prostate cancer treatment drug in US
Pharma major Dr Reddy's Laboratories on Friday said it has launched generic Abiraterone Acetate tablets, used for treatment of prostate cancer, in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 19, 2020 Category: Pharmaceuticals Source Type: news

Metastatic Breast Cancer Symptom Management: 5 Things to Know Metastatic Breast Cancer Symptom Management: 5 Things to Know
By addressing MBC patients'perspectives on meaningful symptom improvement and priorities for symptom management, oncologists can ensure treatment is consistent with patient values and goals.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news

Three Practice-Informing Breast Cancer Trials From ASCO 2020 Three Practice-Informing Breast Cancer Trials From ASCO 2020
Dr Kathy Miller comments on three breast cancer trials presented at this year's virtual ASCO meeting and notes that even a negative trial can have a silver lining.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Cardioprotective Therapy Use Lower With Cancer History
THURSDAY, June 18, 2020 -- Cardioprotective therapies, especially statins and antiplatelets, are underutilized in patients with a history of cancer (CaHx), according to a research letter published in the June 1 issue of JACC: CardioOncology. Rossana... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 18, 2020 Category: Pharmaceuticals Source Type: news

FDA granted accelerated approval to tazemetostat for follicular lymphoma
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 18, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

The COVID-19 Pandemic Shows Why We Must —And How We Can—End Racial Injustice in Health
George Floyd’s violent and senseless death has justly sparked a national outpouring of outrage. Multiracial waves of protesters have called for an end to racism and racial injustice, particularly for Black Americans. Within the context of a grim pandemic, Floyd’s untimely death also magnifies the urgency to address another critical dimension of racial injustice: health inequity in America. It’s long past time to end the disproportionate, unjust and unnatural impact of disease on black Americans and other people of color. Diseases—like COVID-19—do not discriminate. Yet they spread more rapidly ...
Source: TIME: Health - June 18, 2020 Category: Consumer Health News Authors: Howard K. Koh Tags: Uncategorized COVID-19 Source Type: news

QuickStats: Reason for the Most Recent Colonoscopy, Among Adults Aged 50-75 Years Who Had a Test in the Past 10 Years - National Health Interview Survey, United States, 2018
This report describes the percentage of U.S. adults aged 50-75 years without a personal history of colorectal cancer who had a colonoscopy in the past 10 years. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 18, 2020 Category: American Health Tags: Adult Health Cancer Screening Colon cancer prevention MMWR Morbidity & Mortality Weekly Report Colonoscopy Screening Source Type: news

Cardiology Care Ups CV Monitoring, BP Control in Breast Cancer Cardiology Care Ups CV Monitoring, BP Control in Breast Cancer
A new study supports a broader role for cardiologists, beyond the current focus on cancer therapy-related cardiovascular complications.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 18, 2020 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

Spending 30 minutes less time sitting down a day may cut the risks of dying from cancer by 8%
A new study from MD Anderson Cancer Center found that participants who didn't die of cancer spent nearly double the amount of time working out at moderate- or high-intensity levels. (Source: the Mail online | Health)
Source: the Mail online | Health - June 18, 2020 Category: Consumer Health News Source Type: news

Will chemo cause heart failure? A new test may have answers
Yale doctors have developed a technique to predict whether cancer patients receiving the drug doxorubicin are likely to experience heart failure as a result. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 18, 2020 Category: Universities & Medical Training Source Type: news

Increasing physical activity by 30 minutes a day reduces cancer death risk, study says
Light exercise can help older adults with cancer live longer, according to a study published by JAMA Oncology. An extra 30 minutes of light-intensity physical activity daily reduces risk of cancer death by 8 percent. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 18, 2020 Category: Consumer Health News Source Type: news

Hospitals to resume limited visiting hours
New York state has authorized hospitals to reestablish visiting hours for patients, three months after imposing strict rules at the start of the Covid-19 pandemic. The decision this week follows a trial program where a handful of hospitals across New York were permitted to resume limited visiting hours. Roswell Park Comprehensive Cancer Center was among 20 hospitals included in a two-week hospital visitation pilot program. The state Department of Health o n Wednesday directed hospitals to submit… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 18, 2020 Category: Biotechnology Authors: Tracey Drury Source Type: news

Low-Dose CT Lung Cancer Screening Debated, Despite Evidence Low-Dose CT Lung Cancer Screening Debated, Despite Evidence
New findings from the NELSON study support the conclusion of the landmark NLST study -- that high-risk people should undergo screening for lung cancer -- but there are risks and uptake has been slow.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 18, 2020 Category: Cancer & Oncology Tags: Pulmonary Medicine News Source Type: news

Drug Shows'Striking' Efficacy in Hereditary Bleeding Disorder Drug Shows'Striking' Efficacy in Hereditary Bleeding Disorder
The anti-VEGF antibody has shown efficacy in the rare, underrecognized condition of hereditary hemorrhagic telangiectasia, demonstrating significant reductions in both nose and gastric bleeding.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 18, 2020 Category: Intensive Care Tags: Hematology-Oncology News Source Type: news

New Option for AL Amyloidosis: Daratumumab Added to CyBorD New Option for AL Amyloidosis: Daratumumab Added to CyBorD
The addition of daratumumab to the standard CyBorD regimen produced'substantial'increases in hematologic response rates and delayed the time to organ failure.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news